New method of nasal vaccine delivery could lead to better vaccines for HIV and COVID-19

New method of nasal vaccine delivery could lead to better vaccines for HIV and COVID-19
A University of Minnesota assistant professor is part of a team that has developed a new way to effectively deliver vaccines through mucosal tissues in the nose that could lead to better protection against pathogens like human immunodeficiency virus (HIV) and SARS-CoV-2, the virus that causes COVID-19.